Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use with Mortality among Patients with Type 2 Diabetes and Advanced Chronic Kidney Disease
Research output: Contribution to journal › Journal Article › peer-review
28Scopus
citations
Fingerprint
Dive into the research topics of 'Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use with Mortality among Patients with Type 2 Diabetes and Advanced Chronic Kidney Disease'. Together they form a unique fingerprint.